Clinicopathological Features of Small-sized Non-small Cell Lung Cancer with Mediastinal Lymph Node Metastasis
Overview
Affiliations
Introduction: In clinical practice, peripheral small-sized lung cancers with positive mediastinal lymph nodes are sometimes detected. To understand the characteristics of these aggressive tumors, we reviewed the clinicopathological features of small-sized non-small cell lung cancer patients with mediastinal lymph node metastasis resected in our institution.
Methods: We studied 360 patients with small-sized lung lesions with a maximum diameter of 2 cm or less. The clinicopathological characteristics of each patient were reviewed and compared among the subgroups, which were stratified according to pathological nodal status.
Results: 21 patients (5.8%) had a positive mediastinal lymph node. Among them, 17 patients had lung lesions larger than 1.5 cm. No mediastinal nodal involvement was found in patients with squamous cell carcinomas. In contrast, mediastinal nodal involvement was significantly common in patients with poorly differentiated carcinoma (P=0.004) and high serum carcinoembryonic antigen levels detected during preoperative evaluation (P=0.006). None of the 14 patients with upper lobe tumor had a positive subcarinal lymph node. Lower lobe tumors frequently developed extensive multiple-level involvement, which included the upper mediastinum. Radiographic evaluation of pN2 patients using computed tomography revealed a total absence of ground-glass opacity, or the presence of a small area of ground-glass opacity.
Conclusions: Most small-sized non-small cell lung cancer cases with mediastinal lymph node metastasis were invasive adenocarcinoma with poor differentiation, which usually showed a solid shadow without ground-glass opacity on computed tomography.
Feng Y, Cheng B, Zhan S, Liu H, Li J, Chen P Eur J Nucl Med Mol Imaging. 2024; 51(11):3400-3416.
PMID: 38722381 PMC: 11369054. DOI: 10.1007/s00259-024-06740-8.
[Progress in Survival Prognosis of Segmentectomy for Early-stage Non-small Cell Lung Cancer].
Rao S, Ye L, Cui X, Sun Q, Cao R, Xiao S Zhongguo Fei Ai Za Zhi. 2020; 23(9):830-836.
PMID: 32957171 PMC: 7519961. DOI: 10.3779/j.issn.1009-3419.2020.102.21.
Wang Y, Jing L, Wang G J Cardiothorac Surg. 2020; 15(1):121.
PMID: 32782020 PMC: 7422532. DOI: 10.1186/s13019-020-01167-2.
Clinicopathological features of small-sized peripheral squamous cell lung cancer.
Kosaka T, Shimizu K, Nakazawa S, Iijima M, Ohtaki Y, Azuma Y Mol Clin Oncol. 2019; 12(1):69-74.
PMID: 31814978 PMC: 6888248. DOI: 10.3892/mco.2019.1951.
Fu J, Wan Y, Huang T, Wu C, Liu Y, Hsieh M PLoS One. 2018; 13(10):e0206386.
PMID: 30379929 PMC: 6209293. DOI: 10.1371/journal.pone.0206386.